Valeant up 5% premarket after FDA OK of IOP med Vyzulta [Seeking Alpha]
VALEANT PHARMACEUTICALS (VRX)
Last valeant pharmaceuticals earnings: 2/28 07:00 am
Check Earnings Report
US:NYSE Investor Relations:
ir.valeant.com
Company Research
Source: Seeking Alpha
Valeant up 5% premarket after FDA OK of IOP med VyzultaLongs in Valeant Pharmaceuticals (NYSE:VRX) are finally seeing a ray of light. Shares are up5% premarket on modest volume. Yesterday after the close, the company announced the FDA approval of Vyzulta (latanoprostene bunod ophthalmic solution) for lowering intraocular pressure in patients with glaucoma or ocular hypertension.Previously:FDA OKs Valeant's eye drop latanoprostene bunod after CRL issues addressed (Nov. 2)See all stocks on the move »
Show less
Read more
Impact Snapshot
Event Time:
VRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VRX alerts
High impacting VALEANT PHARMACEUTICALS news events
Weekly update
A roundup of the hottest topics